Telix's Illuccix PSMA-PET Imaging Agent Approved in France

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

TelixPharmaceuticals

More Like This

PR Newswire associated0

Illuccix® Approved in the United Kingdom

PR Newswire associated0

Illuccix® Receives European Approval

PR Newswire associated0

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

PR Newswire associated0

Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region

PR Newswire associated0

Telix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®

PR Newswire associated0

Telix Featured in 13 Abstracts at the Annual Congress of the European Association of Nuclear Medicine (EANM)

PR Newswire associated0

NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports

PR Newswire associated0

Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent